HSA/FSA eligible through Truemed
ABOUT
About Enyrgy
Enyrgy Inc. is a private health technology company in Phoenix, Arizona, founded in 2023. Its Enyrgy Vitamin D Primal Light Platform is a home UVB device that emits over 90 percent UVB and under 10 percent UVA, verified by an independent laboratory, the inverse of natural sunlight's roughly 95 percent UVA. A session runs two to four minutes and supports vitamin D synthesis, nitric oxide release and serotonin production. The app calculates each user's dose from their skin type and ends the session automatically.
25,000+
Sessions completed, clean safety record
600+
Users in five countries
Under 1%
Return rate, against an industry average of 5 to 10 percent
2023
Founded in Arizona. Units built in Phoenix
No paid advertising.
What is the evidence
In a 12-week study of the five participants, average vitamin D rose from 39.96 to 84.20 ng/mL, and all five reached the optimal range. It was a small study with no control group, run at four to six sessions per week with skin types II to IV. A larger independent trial is being planned. See the FAQ and The Science.
Leadership
Scott Hansbury, Co-Founder and Chief Executive Officer
Eight startups, five exits totaling over $500 million, and more than twenty years at the intersection of technology and health. Enyrgy is his ninth startup.
David Letourneau, Co-Founder and President
Scaled Alair Homes from 1 location to 100-plus, with $750 million-plus in sales.
Brian Cameron, Chief Financial Officer
Former securities regulator. Brian leads Enyrgy's finance and its investor materials.
Scientific Advisory Board
The board validates the science. All three have reviewed and endorsed the Enyrgy platform.
Dr. Bruce Hollis, PhD
Dr. Hollis has spent forty-plus years at the forefront of vitamin D research. His published work has been cited over 70,000 times, making him one of the most referenced vitamin D scientists in the world. He has been a pioneer in understanding the difference between oral supplementation and UVB-synthesized vitamin D.
Dr. William B. Grant, PhD
Dr. Grant has published more than 350 peer-reviewed articles on the relationship between vitamin D, sunlight, and health outcomes. He used NASA UVB satellite data to establish the epidemiological links between geography, sunlight exposure, and disease incidence across populations. His work provides the research foundation for Enyrgy's market education and the claims we make about how deficiency connects to health risk.
Dr. Samantha Kimball, PhD
Dr. Kimball has spent over twenty years researching vitamin D and has published more than 100 peer-reviewed papers on the subject. She is a pioneer in MED-based phototherapy protocol design. She built the Minimal Erythemal Dose protocol that governs every Enyrgy session, ensuring that the safety standards are grounded in medical science rather than engineering assumptions.
Medical Director
Derrick Holman, M.D.
Genomic medicine expert, entrepreneur and biotechnology investor, based in Newport Beach, California, and managing director of Age Reversal Ventures. Dr. Holman oversees the clinical questions that govern the platform itself: who it is suitable for, how it responds to what a user tells it, and where it defers to a person's own physician. He also leads Enyrgy's direct outreach to the wellness community throughout North America.
Financial Advisory Council
The council advises Enyrgy on capital strategy, business development and governance.
Ravi Bhatia, Chairman
Principal and chief investment officer at Verano Capital Partners, an Orange County firm providing investment banking, strategic advisory and M&A services to middle-market companies. Big Four and Fortune 500 background in business advisory, transformation and corporate development. Executive MBA, UCLA Anderson. Advises on governance and business development.
Paul Sanchez
Partner at Terra Rossa Family Office and founder and manager of The Zenith Fund. Previously 30 years as an executive recruiter placing C-level executives. Advises on financial planning and capital strategy.
Derrick Holman, M.D.
Also serves as Medical Director. See the Medical Director section above.
Natalia Lantonio
Focuses on domestic and international business development: domestic buildout, international expansion, market opportunity and cross-border growth. She has spent a decade engaged in cross-border business verticals including technology, entertainment and real estate. She has advised technology start-ups on international expansion and United States market entry, and built partnerships in the Middle East through Sustainable Success Management Consulting. At MagicQuest Entertainment, a Hollywood motion picture company, she oversaw international feature film development, negotiated agreements during the development of a $30 million picture, and cut administrative costs by 30 percent through vendor negotiation. She is trained as an international lawyer and was previously in-house legal counsel at RESO Holding Company. Based in Newport Beach, California.
Mickey Payne
Focuses on long-term positioning and exit strategy. President of Goldenbridge Investments, LLC, where he specializes in raising capital, structuring investment transactions and managing portfolios across alternative assets and private equity funds. His career spans more than 30 years in financial services, in roles including Capital Raising Specialist, Financial Advisor, Vice President of Investments and Director of Operations. He has structured more than 30 deals, each averaging approximately $100M, and works with family offices, registered investment advisors and ultra-high-net-worth individuals. He has also advised individuals, families and institutional clients on investment, tax and retirement strategy. Graduated from the University of Central Florida in Economics and Statistics, holds PFP and CPFA certifications from the University of California, Irvine, and holds a Series 65 securities license. Based in Los Angeles.
Press
Sept. 22, 2026. Enyrgy Appoints Dr. Derrick Holman as Medical Director
Media contact: [email protected], (888) 316-1695.
Must be 18 years or older to be eligible for treatment. Enyrgy is not a medical device, and makes no medical claims, implied or otherwise stated, for the use of this device other than the fact it will emit UV light within the ranges and levels per the product specification. Statements regarding the Enyrgy device have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.
© 2026, Enyrgy Inc.